Oppenheimer analyst, Leah Rush Cann, reiterated her Outperform on Amgen (NASDAQ: AMGN) and raised her price target to $205 from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE